The majority of DLBCL with MYC and BCL6 translocation also had BCL2 translocation or TP53 mutation, and the number of cases with only MYC and BCL6 translocation is small for assessing the prognostic impact of BCL6 translocation in MYC translocation positive DLBCL. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.